STING1 and cancer: Finally, it is worth mentioning that during the review process of our manuscript, a recent work showed that chronic activation of cGAS-STING is associated with cancer cell metastasis [44], and through this conjugation with CDDP, the STING agonist MSA-2 can enter cancer cells in large quantities, potentially disrupting the chronic activation of this pathway.